{
    "SLC47A2": {
        "expression": [
            {
                "Organ": "Kidney*",
                "Source": "Mean across all PMT Samples",
                "Relative Expression": 5.03
            },
            {
                "Organ": "Liver",
                "Source": "Mean across all PMT Samples",
                "Relative Expression": 0.293
            }
        ],
        "inhibitors": [
            {
                "Inhibitor": "Amantadine",
                "IC50 (μM)": null,
                "Ki (μM)": 1167.0,
                "Substrate used": "Tetraethylammonium",
                "Cell System": "HEK293-MATE2",
                "Reference": "Tsuda, 2009"
            },
            {
                "Inhibitor": "Cetirizine",
                "IC50 (μM)": null,
                "Ki (μM)": 817.6,
                "Substrate used": "Tetraethylammonium",
                "Cell System": "HEK293-MATE2",
                "Reference": "Tsuda, 2009"
            },
            {
                "Inhibitor": "Chlorpheniramine",
                "IC50 (μM)": null,
                "Ki (μM)": 191.2,
                "Substrate used": "Tetraethylammonium",
                "Cell System": "HEK293-MATE2",
                "Reference": "Tsuda, 2009"
            },
            {
                "Inhibitor": "Cimetidine",
                "IC50 (μM)": null,
                "Ki (μM)": 7.3,
                "Substrate used": "Tetraethylammonium",
                "Cell System": "HEK293-MATE2",
                "Reference": "Tsuda, 2009"
            },
            {
                "Inhibitor": "Cimetidine",
                "IC50 (μM)": null,
                "Ki (μM)": 2.1,
                "Substrate used": "Tetraethylammonium",
                "Cell System": "HEK293-MATE2K",
                "Reference": "Ito, 2012"
            },
            {
                "Inhibitor": "Desipramine",
                "IC50 (μM)": null,
                "Ki (μM)": 283.0,
                "Substrate used": "Tetraethylammonium",
                "Cell System": "HEK293-MATE2",
                "Reference": "Tsuda, 2009"
            },
            {
                "Inhibitor": "Diltiazem",
                "IC50 (μM)": null,
                "Ki (μM)": 117.0,
                "Substrate used": "Tetraethylammonium",
                "Cell System": "HEK293-MATE2",
                "Reference": "Tsuda, 2009"
            },
            {
                "Inhibitor": "Diphenhydramine",
                "IC50 (μM)": null,
                "Ki (μM)": 266.5,
                "Substrate used": "Tetraethylammonium",
                "Cell System": "HEK293-MATE2",
                "Reference": "Tsuda, 2009"
            },
            {
                "Inhibitor": "Disopyramide",
                "IC50 (μM)": null,
                "Ki (μM)": 291.6,
                "Substrate used": "Tetraethylammonium",
                "Cell System": "HEK293-MATE2",
                "Reference": "Tsuda, 2009"
            },
            {
                "Inhibitor": "DX-619",
                "IC50 (μM)": null,
                "Ki (μM)": 0.1,
                "Substrate used": "Creatinine",
                "Cell System": "HEK293-MATE2K",
                "Reference": "Imamura, 2011"
            },
            {
                "Inhibitor": "Famotidine",
                "IC50 (μM)": null,
                "Ki (μM)": 9.7,
                "Substrate used": "Tetraethylammonium",
                "Cell System": "HEK293-MATE2",
                "Reference": "Tsuda, 2009"
            },
            {
                "Inhibitor": "Imipramine",
                "IC50 (μM)": null,
                "Ki (μM)": 182.9,
                "Substrate used": "Tetraethylammonium",
                "Cell System": "HEK293-MATE2",
                "Reference": "Tsuda, 2009"
            },
            {
                "Inhibitor": "Metformin",
                "IC50 (μM)": null,
                "Ki (μM)": 6515.7,
                "Substrate used": "Tetraethylammonium",
                "Cell System": "HEK293-MATE2",
                "Reference": "Tsuda, 2009"
            },
            {
                "Inhibitor": "N-butylpyridinium chloride (NBuPy-Cl)",
                "IC50 (μM)": 1.6,
                "Ki (μM)": null,
                "Substrate used": "1-methyl-4-phenylpyridinium (MPP+)",
                "Cell System": "CHO-MATE2K",
                "Reference": "Cheng, 2011"
            },
            {
                "Inhibitor": "Pramipexole",
                "IC50 (μM)": null,
                "Ki (μM)": 24.1,
                "Substrate used": "Tetraethylammonium",
                "Cell System": "HEK293-MATE2",
                "Reference": "Tsuda, 2009"
            },
            {
                "Inhibitor": "Procainamide",
                "IC50 (μM)": null,
                "Ki (μM)": 178.1,
                "Substrate used": "Tetraethylammonium",
                "Cell System": "HEK293-MATE2",
                "Reference": "Tsuda, 2009"
            },
            {
                "Inhibitor": "Quinidine",
                "IC50 (μM)": null,
                "Ki (μM)": 23.1,
                "Substrate used": "Tetraethylammonium",
                "Cell System": "HEK293-MATE2",
                "Reference": "Tsuda, 2009"
            },
            {
                "Inhibitor": "Ranitidine",
                "IC50 (μM)": null,
                "Ki (μM)": 25.0,
                "Substrate used": "Tetraethylammonium",
                "Cell System": "HEK293-MATE2",
                "Reference": "Tsuda, 2009"
            },
            {
                "Inhibitor": "Talipexole",
                "IC50 (μM)": null,
                "Ki (μM)": 119.5,
                "Substrate used": "Tetraethylammonium",
                "Cell System": "HEK293-MATE2",
                "Reference": "Tsuda, 2009"
            },
            {
                "Inhibitor": "Verapamil",
                "IC50 (μM)": null,
                "Ki (μM)": 32.1,
                "Substrate used": "Tetraethylammonium",
                "Cell System": "HEK293-MATE2",
                "Reference": "Tsuda, 2009"
            }
        ],
        "substrates": [
            {
                "Substrate": "Acyclovir",
                "Km (μM)": 4320.0,
                "Cell System": "HEK293-MATE2K",
                "Reference": "Tanihara, 2007"
            },
            {
                "Substrate": "Cimetidine",
                "Km (μM)": 120.0,
                "Cell System": "HEK293-MATE2K",
                "Reference": "Tanihara, 2007"
            },
            {
                "Substrate": "Cimetidine",
                "Km (μM)": 370.0,
                "Cell System": "HEK293-MATE2K",
                "Reference": "Masuda, 2006"
            },
            {
                "Substrate": "Estrone 3-sulfate",
                "Km (μM)": 850.0,
                "Cell System": "HEK293-MATE2K",
                "Reference": "Tanihara, 2007"
            },
            {
                "Substrate": "Ganciclovir",
                "Km (μM)": 4280.0,
                "Cell System": "HEK293-MATE2K",
                "Reference": "Tanihara, 2007"
            },
            {
                "Substrate": "Guanidine",
                "Km (μM)": 4200.0,
                "Cell System": "HEK293-MATE2K",
                "Reference": "Tanihara, 2007"
            },
            {
                "Substrate": "Metformin",
                "Km (μM)": 1050.0,
                "Cell System": "HEK293-MATE2K",
                "Reference": "Masuda, 2006"
            },
            {
                "Substrate": "Metformin",
                "Km (μM)": 1980.0,
                "Cell System": "HEK293-MATE2K",
                "Reference": "Tanihara, 2007"
            },
            {
                "Substrate": "N-methylpyridinium",
                "Km (μM)": 93.5,
                "Cell System": "HEK293-MATE2K",
                "Reference": "Masuda, 2006"
            },
            {
                "Substrate": "N-methylpyridinium",
                "Km (μM)": 110.0,
                "Cell System": "HEK293-MATE2K",
                "Reference": "Tanihara, 2007"
            },
            {
                "Substrate": "Procainamide",
                "Km (μM)": 1580.0,
                "Cell System": "HEK293-MATE2K",
                "Reference": "Tanihara, 2007"
            },
            {
                "Substrate": "Procainamide",
                "Km (μM)": 4100.0,
                "Cell System": "HEK293-MATE2K",
                "Reference": "Masuda, 2006"
            },
            {
                "Substrate": "Tetraethylammonium",
                "Km (μM)": 760.0,
                "Cell System": "HEK293-MATE2K",
                "Reference": "Tanihara, 2007"
            },
            {
                "Substrate": "Tetraethylammonium",
                "Km (μM)": 830.0,
                "Cell System": "HEK293-MATE2K",
                "Reference": "Masuda, 2006"
            },
            {
                "Substrate": "Topotecan",
                "Km (μM)": 60.0,
                "Cell System": "HEK293-MATE2K",
                "Reference": "Tanihara, 2007"
            }
        ],
        "ddi": [
            {
                "DDI": "1",
                "Implicated Transporter": "OCTs/MATEs",
                "Interacting Drug": "Cetirizine",
                "Affected Drug": "Pilsicainide",
                "AUC": "1.4",
                "Cmax": "NS",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Tsuruoka, 2006",
                "More Details": "DDI 1"
            },
            {
                "DDI": "2",
                "Implicated Transporter": "OCTs/MATEs",
                "Interacting Drug": "Cimetidine",
                "Affected Drug": "Cephalexin",
                "AUC": "NS",
                "Cmax": "NS",
                "CLR": "0.8",
                "CL/F": "0.8",
                "t1/2": "NS",
                "Effect on PD": "ND",
                "Reference": "van, 1986",
                "More Details": "DDI 2"
            },
            {
                "DDI": "3",
                "Implicated Transporter": "OCTs/MATEs",
                "Interacting Drug": "Cimetidine",
                "Affected Drug": "Dofetilide",
                "AUC": "1.5",
                "Cmax": "1.3",
                "CLR": "0.7",
                "CL/F": "0.7",
                "t1/2": "1.3",
                "Effect on PD": "yes",
                "Reference": "Abel, 2000",
                "More Details": "DDI 3"
            },
            {
                "DDI": "4",
                "Implicated Transporter": "OCTs/MATEs",
                "Interacting Drug": "Cimetidine",
                "Affected Drug": "Metformin",
                "AUC": "1.5",
                "Cmax": "1.7",
                "CLR": "0.7",
                "CL/F": "ND",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Somogyi, 1987",
                "More Details": "DDI 4"
            },
            {
                "DDI": "5",
                "Implicated Transporter": "OCTs/MATEs",
                "Interacting Drug": "Cimetidine",
                "Affected Drug": "Pilsicainide",
                "AUC": "1.3",
                "Cmax": "NS",
                "CLR": "0.7",
                "CL/F": "0.7",
                "t1/2": "1.2",
                "Effect on PD": "ND",
                "Reference": "Shiga, 2000",
                "More Details": "DDI 5"
            },
            {
                "DDI": "6",
                "Implicated Transporter": "OCTs/MATEs",
                "Interacting Drug": "Cimetidine",
                "Affected Drug": "Pindolol (S-enantiomer)",
                "AUC": "1.4",
                "Cmax": "1.3",
                "CLR": "0.7",
                "CL/F": "ND",
                "t1/2": "NS",
                "Effect on PD": "ND",
                "Reference": "Somogyi, 1992",
                "More Details": "DDI 6"
            },
            {
                "DDI": "7",
                "Implicated Transporter": "OCTs/MATEs",
                "Interacting Drug": "Cimetidine",
                "Affected Drug": "Procainamide",
                "AUC": "1.4",
                "Cmax": "NS",
                "CLR": "0.6",
                "CL/F": "ND",
                "t1/2": "1.3",
                "Effect on PD": "ND",
                "Reference": "Somogyi, 1983",
                "More Details": "DDI 7"
            },
            {
                "DDI": "8",
                "Implicated Transporter": "OCTs/MATEs",
                "Interacting Drug": "Cimetidine",
                "Affected Drug": "Ranitidine",
                "AUC": "1.3",
                "Cmax": "NS",
                "CLR": "0.7",
                "CL/F": "ND",
                "t1/2": "1.3",
                "Effect on PD": "ND",
                "Reference": "van, 1986",
                "More Details": "DDI 8"
            },
            {
                "DDI": "9",
                "Implicated Transporter": "OCTs/MATEs",
                "Interacting Drug": "Cimetidine",
                "Affected Drug": "Varenicline",
                "AUC": "1.3",
                "Cmax": "ND",
                "CLR": "0.8",
                "CL/F": "0.8",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Feng, 2008",
                "More Details": "DDI 9"
            },
            {
                "DDI": "10",
                "Implicated Transporter": "MATEs",
                "Interacting Drug": "Pyrimethamine",
                "Affected Drug": "Metformin",
                "AUC": "1.4",
                "Cmax": "1.4",
                "CLR": "0.6",
                "CL/F": "ND",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Kusuhara, 2011",
                "More Details": "DDI 10"
            }
        ]
    }
}